NASDAQ •
Healthcare •
Medical Devices •
Quote as of 05/05/2026 16:00
Company Profile
IndustryMedical Devices
SectorHealthcare
ExchangeNASDAQ
Market Capitalization674.16 mln
Float27.87 mln
Earnings Date05/13/2026
EPS
0.18
Overpriced
P / E
91.22
Speculative
Piotroski F-Score
6
/ 9
Solid
Beneish M-Score
-1.3
Manipulation likely
Relative Strength
85
/ 100
Strongly outperforming
Debt / Equity
0.09
Debt-free
Business Description
Founded in Jerusalem in 2003, BrainsWay designs and markets a brain stimulation technology that treats a wide range of mental health and neurological conditions without surgery or medication. Its core device uses deep magnetic fields to target specific areas of the brain, helping patients with conditions such as depression, OCD, addiction, PTSD, and Parkinson's disease, among others. The company works with psychiatrists, hospitals, and medical centers across the United States, East Asia, and other markets worldwide.
